Ameritas Advisory Services’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.2K Sell
200
-10
-5% -$541 ﹤0.01% 1486
2026
Q2
$11.5K Buy
+210
New +$8.59K ﹤0.01% 1446
2025
Q4
– Sell
-700
Closed -$25.3K – 1992
2025
Q3
$25.3K Hold
700
– – ﹤0.01% 1359
2025
Q2
$25.2K Buy
+700
New +$26.1K ﹤0.01% 1641
2023
Q2
– Sell
-1,125
Closed -$25.5K – 2331
2023
Q1
$25.5K Buy
+1,125
New +$17.1K ﹤0.01% 1535

Other funds holding TGTX

Ameritas Advisory Services's TGTX Position: Q3 2026 in Review

Ameritas Advisory Services reduced its TG Therapeutics (TGTX) stake by 4.8% in Q3 2026, selling an estimated $541 and leaving 200 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1486.

Ameritas Advisory Services first reported a position in TGTX in Q1 2023 and has held it in 5 quarters since. The position peaked at $25.5K in Q1 2023. 455 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Ameritas Advisory Services held 200 shares of TG Therapeutics worth $11.2K as of Q3 2026.
  • Ameritas Advisory Services sold 10 TG Therapeutics shares in Q3 2026, an estimated $541.
  • TG Therapeutics made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q3 2026, its #1486 holding.
  • Ameritas Advisory Services first reported a position in TG Therapeutics in Q1 2023 and has held it in 5 quarters since.
  • Ameritas Advisory Services's TG Therapeutics position peaked at $25.5K in Q1 2023.
  • 455 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Ameritas Advisory Services's 13F filing for Q3 2026, filed 12 Nov 2026.